| MeSH term | MeSH ID | Detail |
|---|---|---|
| Acquired Hyperostosis Syndrome | D020083 | 1 associated lipids |
| Eisenmenger Complex | D004541 | 1 associated lipids |
| Myelitis, Transverse | D009188 | 1 associated lipids |
| Epiglottitis | D004826 | 1 associated lipids |
| Tick Bites | D064927 | 1 associated lipids |
| Focal Nodular Hyperplasia | D020518 | 1 associated lipids |
| Furcation Defects | D017823 | 1 associated lipids |
| Granulomatous Mastitis | D058890 | 1 associated lipids |
| Syncope, Vasovagal | D019462 | 1 associated lipids |
| Achondroplasia | D000130 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Davies G and Wilson R | Prophylactic antibiotic treatment of bronchiectasis with azithromycin. | 2004 | Thorax | pmid:15170047 |
| Dorrell L et al. | Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease. | 1994 | Thorax | pmid:8016806 |
| Idris SF et al. | Azithromycin therapy for neutrophilic airways disease: myth or magic? | 2009 | Thorax | pmid:19252016 |
| Clement A et al. | Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial. | 2006 | Thorax | pmid:16809416 |
| Brusselle GG et al. | Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. | 2013 | Thorax | pmid:23291349 |
| Slater M et al. | The impact of azithromycin therapy on the airway microbiota in asthma. | 2014 | Thorax | pmid:24287164 |
| Murphy DM et al. | Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts. | 2007 | Thorax | pmid:17726173 |
| Wolter J et al. | Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. | 2002 | Thorax | pmid:11867823 |
| Brill SE et al. | Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial. | 2015 | Thorax | pmid:26179246 |
| Segal LN et al. | Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung. | 2017 | Thorax | pmid:27486204 |
| Hahn DL | Azithromycin and severe asthma. | 2013 | Thorax | pmid:23392446 |
| Gibson PG | Macrolides for yet another chronic airway disease: severe asthma? | 2013 | Thorax | pmid:23349219 |
| Brusselle GG | Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases? | 2015 | Thorax | pmid:25870311 |
| Corris PA et al. | A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. | 2015 | Thorax | pmid:25714615 |
| Ollivier V et al. | Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells. | 2005 | Thromb. Haemost. | pmid:16113783 |
| VÃchová B et al. | First molecular identification of Babesia gibsoni in dogs from Slovakia, central Europe. | 2016 | Ticks Tick Borne Dis | pmid:26304014 |
| Farber FR et al. | Atraumatic splenic rupture from Babesia: A disease of the otherwise healthy patient. | 2015 | Ticks Tick Borne Dis | pmid:26123434 |
| Nilsen E | [Should azithromycin dosing be changed?]. | 2011 | Tidsskr. Nor. Laegeforen. | pmid:21844939 |
| Rizvi SM et al. | [Young boy with fever, sore throat, sore lips and bullous rashes]. | 2013 | Tidsskr. Nor. Laegeforen. | pmid:23552160 |
| Moi H | [New treatment guidelines for gonorrhea]. | 2013 | Tidsskr. Nor. Laegeforen. | pmid:23759772 |
| Jernberg EJ and Moi H | [Mycoplasma genitalium--aetiological agent of sexually transmitted infection]. | 2007 | Tidsskr. Nor. Laegeforen. | pmid:17828317 |
| Moi H et al. | [Reduce the use of one-dose azithromycin]. | 2011 | Tidsskr. Nor. Laegeforen. | pmid:21494300 |
| van den Wollenberg L et al. | Lawsonia intracellularis-associated proliferative enteritis in weanling foals in the Netherlands. | 2011 | Tijdschr Diergeneeskd | pmid:22111417 |
| Kaneko A and Sasaki J | Comparison of in vitro activity of azithromycin and ampicillin against 31 isolates of Streptococcus milleri. | 1997 | Tokai J. Exp. Clin. Med. | pmid:9618830 |
| Montenez JP et al. | Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. | 1999 | Toxicol. Appl. Pharmacol. | pmid:10198278 |
| Mahgoub A et al. | Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. | 2005 | Toxicol. Appl. Pharmacol. | pmid:15885263 |
| Baronas ET et al. | Biomarkers to monitor drug-induced phospholipidosis. | 2007 | Toxicol. Appl. Pharmacol. | pmid:17156806 |
| Ferslew BC and Brouwer KL | Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates. | 2014 | Toxicol. Sci. | pmid:24563379 |
| Liu Y et al. | One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health. | 2014 | Toxicology | pmid:24613571 |
| Walsh MS et al. | Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: a community-based study. | 2015 | Trans. R. Soc. Trop. Med. Hyg. | pmid:25732755 |
| Emary K et al. | Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin. | 2012 | Trans. R. Soc. Trop. Med. Hyg. | pmid:23122884 |
| Shaio MF and Yang KD | Response of babesiosis to a combined regimen of quinine and azithromycin. | 1997 Mar-Apr | Trans. R. Soc. Trop. Med. Hyg. | pmid:9196774 |
| Shanks GD et al. | Azithromycin prophylaxis prevents epidemic dysentery. | 1996 May-Jun | Trans. R. Soc. Trop. Med. Hyg. | pmid:8758091 |
| Mahmud ZH et al. | Phenotypic and genotypic characteristics of Vibrio cholerae O1 isolated from the Sierra Leone cholera outbreak in 2012. | 2014 | Trans. R. Soc. Trop. Med. Hyg. | pmid:25233936 |
| Parry CM | The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. | 2004 | Trans. R. Soc. Trop. Med. Hyg. | pmid:15138078 |
| Alexander ND et al. | An index of community ocular Chlamydia trachomatis load for control of trachoma. | 2005 | Trans. R. Soc. Trop. Med. Hyg. | pmid:15653119 |
| Marks M | Yaws: towards the WHO eradication target. | 2016 | Trans. R. Soc. Trop. Med. Hyg. | pmid:27268712 |
| Pukrittayakamee S et al. | Therapeutic responses to antibacterial drugs in vivax malaria. | 2001 Sep-Oct | Trans. R. Soc. Trop. Med. Hyg. | pmid:11706666 |
| Basilion EV et al. | Height as a proxy for weight in determining azithromycin treatment for paediatric trachoma. | 2002 Nov-Dec | Trans. R. Soc. Trop. Med. Hyg. | pmid:12625152 |
| Desmond N et al. | Acceptability of azithromycin for the control of trachoma in Northern Tanzania. | 2005 | Trans. R. Soc. Trop. Med. Hyg. | pmid:15979657 |
| Basilion EV et al. | Simplification and improvement of height-based azithromycin treatment for paediatric trachoma. | 2005 | Trans. R. Soc. Trop. Med. Hyg. | pmid:15550255 |
| Medina AM et al. | Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru. | 2015 | Trans. R. Soc. Trop. Med. Hyg. | pmid:26175267 |
| Ivetic Tkalcevic V et al. | Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. | 2012 | Transl Res | pmid:22677362 |
| Mascarenhas TR et al. | Tick-borne illness after transplantation: Case and review. | 2018 | Transpl Infect Dis | pmid:29277955 |
| Denkinger CM et al. | Cryptosporidium parvum-associated sclerosing cholangitis in a liver transplant patient. | 2008 | Transpl Infect Dis | pmid:17605744 |
| Scolfaro C et al. | Possible donor-recipient bartonellosis transmission in a pediatric liver transplant. | 2008 | Transpl Infect Dis | pmid:18651873 |
| Franco M et al. | Pulmonary mycobacterial spindle cell pseudotumor in a lung transplant patient: progression without therapy and response to therapy. | 2015 | Transpl Infect Dis | pmid:25846671 |
| Verleden SE et al. | Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients. | 2011 | Transpl. Immunol. | pmid:21740970 |
| Vandermeulen E et al. | BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance. | 2015 | Transpl. Immunol. | pmid:26168736 |
| Mori T et al. | Tacrolimus-azithromycin interaction in a recipient of allogeneic bone marrow transplantation. | 2005 | Transpl. Int. | pmid:15910307 |
| Bellon H et al. | Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro: assessing mechanisms and possible treatment options. | 2017 | Transpl. Int. | pmid:28078769 |
| Geudens N et al. | Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury. | 2008 | Transpl. Int. | pmid:18435685 |
| Verleden GM et al. | Obliterative bronchiolitis following lung transplantation: from old to new concepts? | 2009 | Transpl. Int. | pmid:19490538 |
| Verleden GM et al. | Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. | 2011 | Transpl. Int. | pmid:21401732 |
| Verleden GM et al. | Current views on chronic rejection after lung transplantation. | 2015 | Transpl. Int. | pmid:25857869 |
| Kwun WH et al. | Effect of azithromycin in the treartment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. | 2003 | Transplant. Proc. | pmid:12591416 |
| Nafar M et al. | A comparison between the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingival overgrowth in kidney transplant patients. | 2003 | Transplant. Proc. | pmid:14612094 |
| Puig JM et al. | Treatment of gingival hyperplasia secondary to cyclosporine by the new macrolide azithromycin. | 1997 | Transplant. Proc. | pmid:9270772 |
| Wirnsberger GH et al. | Effect of antibiotic treatment with azithromycin on cyclosporine A-induced gingival hyperplasia among renal transplant recipients. | 1998 | Transplant. Proc. | pmid:9723411 |
| Boran M et al. | Improvement in cyclosporine A associated gingival hyperplasia with azithromycin therapy. | 1996 | Transplant. Proc. | pmid:8769234 |
| Citterio F et al. | Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe. | 2001 | Transplant. Proc. | pmid:11377476 |
| Verleden GM et al. | Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation. | 2009 | Transplant. Proc. | pmid:19545735 |
| Tokgöz B et al. | Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. | 2004 | Transplant. Proc. | pmid:15621128 |
| Shullo MA et al. | Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. | 2010 | Transplant. Proc. | pmid:20620540 |
| Lendermon EA et al. | Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet Mouse Lung Allograft Recipients. | 2018 | Transplant. Proc. | pmid:29880387 |
| Nash MM and Zaltzman JS | Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. | 1998 | Transplantation | pmid:9665078 |
| Verleden GM and Dupont LJ | Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. | 2004 | Transplantation | pmid:15167610 |
| Imai N et al. | A case of Campylobacter enteritis in a renal transplant recipient. | 2013 | Transplantation | pmid:23774778 |
| Vos R et al. | Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. | 2012 | Transplantation | pmid:22461039 |
| Gottlieb J et al. | Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. | 2008 | Transplantation | pmid:18192909 |
| Verleden SE et al. | Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? | 2013 | Transplantation | pmid:23425818 |
| Wirnsberger GH and Pfragner R | Comment on "Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients" by Nash and Zaltzman. | 1999 | Transplantation | pmid:10342326 |
| Requena-Méndez A et al. | Enteric fever in Barcelona: Changing patterns of importation and antibiotic resistance. | Travel Med Infect Dis | pmid:27890811 | |
| Dave J et al. | Trends in antibiotic susceptibility of enteric fever isolates in East London. | Travel Med Infect Dis | pmid:25964222 | |
| Baneke A | Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness. | 2012 | Travel Med Infect Dis | pmid:22326056 |
| Swanson RN et al. | Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study. | 2005 | Treat Respir Med | pmid:15725048 |
| Cymbala AA et al. | The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. | 2005 | Treat Respir Med | pmid:15813663 |
| Zervos M et al. | Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. | 2004 | Treat Respir Med | pmid:15606222 |
| What's in the water? | 1995 Mar-Apr | Treat Rev | pmid:11362299 | |
| Azithro once a week for MAC. | 1998 | TreatmentUpdate | pmid:11365625 | |
| Infection fighters. MAC prevention takes a holiday. | 2000 | TreatmentUpdate | pmid:12132450 | |
| Noedl H | ABC - antibiotics-based combinations for the treatment of severe malaria? | 2009 | Trends Parasitol. | pmid:19819757 |
| Chang AB et al. | Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. | 2012 | Trials | pmid:22937736 |
| Pokharel S et al. | Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. | 2017 | Trials | pmid:28969659 |
| Uzun S et al. | Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial. | 2012 | Trials | pmid:22682323 |
| Chang AB et al. | Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. | 2013 | Trials | pmid:23421781 |
| Chang AB et al. | Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol. | 2011 | Trials | pmid:21492416 |
| Brittain C et al. | Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. | 2016 | Trials | pmid:27881151 |
| Bandyopadhyay R et al. | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. | 2018 | Trop Doct | pmid:29495943 |
| Rajapakse S et al. | Drug treatment of scrub typhus. | 2011 | Trop Doct | pmid:21172901 |
| Fegan D et al. | Resurgence of yaws in Tanna, Vanuatu: time for a new approach? | 2010 | Trop Doct | pmid:20305095 |
| Mahajan SK et al. | Scrub typhus and malaria co-infection causing severe sepsis. | 2014 | Trop Doct | pmid:24249027 |
| Fegan D et al. | Tropical leg ulcers in children: more than yaws. | 2016 | Trop Doct | pmid:26289420 |
| Lubell Y et al. | Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics. | 2011 | Trop. Med. Int. Health | pmid:21740488 |
| Wong RP et al. | In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea. | 2010 | Trop. Med. Int. Health | pmid:20070627 |
| Edwards T et al. | Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin. | 2008 | Trop. Med. Int. Health | pmid:18282237 |
| Luntamo M et al. | The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. | 2013 | Trop. Med. Int. Health | pmid:23432801 |
| Hart JD et al. | Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children. | 2014 | Trop. Med. Int. Health | pmid:24433194 |
| Chico RM and Chandramohan D | Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. | 2011 | Trop. Med. Int. Health | pmid:21477099 |
| de Vries PI et al. | Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. | 1999 | Trop. Med. Int. Health | pmid:10402979 |